Among these, miR-147, miR-124, and miR-193-3p have been shown to act as tumor suppressors for the EGFR1 pathway, inhibiting the proliferation of HER2-positive breast cancers [108]. The gene discussed is ERBB2; the disease is breast carcinoma.